GlassScriptPhysician profile
Phuoc Ngo
NPI 1154992428
$4,244.23
in general payments reported to CMS, 2019-2025
36 companies · $895 in 2025
The $895 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $961 · 2023: $965 · 2024: $1,297 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $759.85 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $710.37 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.71 | 2022-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $296.67 | 2021-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $232.92 | 2022-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $217.38 | 2023-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $165.58 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $151.41 | 2023-2025 | Rexulti |
| Abiomed | $136.47 | 2024-2025 | Impella |
| Exact Sciences Corporation | $136.13 | 2024-2025 | Cologuard Collection Kit |
| Abbvie INC. | $133.32 | 2022 | |
| Glaxosmithkline, LLC. | $99.19 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $88.18 | 2021-2023 | Belsomra, Steglujan, Steglatro |
| Bayer Healthcare Pharmaceuticals INC. | $58.54 | 2022-2025 | |
| Dexcom, INC. | $58.46 | 2024-2025 | Dexcom G6 Transmitter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $56.67 | 2022-2024 | Trintellix |
| Amarin Pharma, INC. | $53.44 | 2021-2023 | |
| Phathom Pharmaceuticals, INC. | $46.43 | 2024-2025 | Voquezna |
| Axonics, INC. | $39.67 | 2023 | Axonics |
| Biohaven Pharmaceutical Holding Company LTD. | $39.20 | 2022 | |
| Edwards Lifesciences Corporation | $38.76 | 2022-2025 | Sapien 3 Ultra Resilia |
| Biosense Webster, INC. | $33.19 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.16 | 2024 | |
| Inspire Medical Systems, INC. | $31.57 | 2024-2025 | Inspire |
| Astellas Pharma US INC | $28.40 | 2024 | Veozah |
| Radius Health, INC. | $27.94 | 2023-2024 | Tymlos |
| Novartis Pharmaceuticals Corporation | $27.30 | 2022 | |
| Medtronic, INC. | $21.89 | 2022 | |
| Corium, LLC | $20.69 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.85 | 2025 | Edarbi |
| Procept Biorobotics Corporation | $19.18 | 2024 | Aquabeam System |
| Gilead Sciences, INC. | $17.89 | 2024 | |
| Inari Medical, INC. | $17.21 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ibsa Pharma INC. | $16.07 | 2025 | Flector, Licart, Tirosint |
| Idorsia Pharmaceuticals US INC | $14.75 | 2022 | |
| Neos Therapeutics, LP | $13.79 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phuoc Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.